Related Experiment Video

Updated: Jul 7, 2026

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
15:05

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

The epidermal growth factor receptor family: biology driving targeted therapeutics

M J Wieduwilt1, M M Moasser

  • 1Department of Medicine, Comprehensive Cancer Center, University of California-San Francisco, San Francisco, CA 94143-0875, USA.

Cellular and Molecular Life Sciences : CMLS
|February 9, 2008
PubMed

Insights

The epidermal growth factor receptor (EGFR) family, known as ErbBs, are crucial for cell functions and development. Dysregulation of ErbB signaling is linked to cancer, driving the development of targeted therapies.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • The epidermal growth factor receptor (EGFR) family, or ErbBs, are receptor tyrosine kinases vital for cellular processes.
  • These receptors have overlapping and distinct roles in mammalian development and tissue homeostasis.
  • Aberrant ErbB signaling is implicated in numerous human diseases, particularly cancer.

Purpose of the Study:

  • To review the fundamental biology of ErbB receptors.
  • To discuss their structure, signaling pathways, and regulatory mechanisms.
  • To highlight their involvement in development and disease, and their therapeutic targeting in cancer.

Main Methods:

  • Literature review of ErbB receptor biology.
  • Analysis of ErbB roles in mammalian development and adult tissue maintenance.
  • Examination of ErbB dysregulation in human diseases, especially cancer.
  • Overview of targeted cancer therapies developed based on ErbB signaling.

Main Results:

  • ErbB receptors regulate critical cell functions like proliferation, survival, differentiation, and migration.
  • Their functions are essential for both embryonic development and adult tissue maintenance.
  • Understanding ErbB biology has led to significant advancements in targeted cancer therapies over the past 15 years.

Conclusions:

  • ErbB receptors are central to normal physiology and disease pathogenesis.
  • Their complex biology provides a rich foundation for developing effective cancer treatments.
  • Targeting ErbB signaling remains a key strategy in oncology.

More Related Videos

Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells08:28

Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells

Published on: May 9, 2025

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...